Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mobile phase gradient: 0-0.1 min, 100% B
MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state
doi: 10.3390/ijms20236003 95 DixonSJLembergKMLamprechtMRSkoutaRZaitsevEMGleasonCEet al
Reported side effects (minimal) Most users report zero side effects - Epithalon remarkably well-tolerated Occasional reported effects: Mild injection site reactions (redness, slight swelling) Temporary headache (first 1-2 days) Slight drowsiness initially (adjusting to improved sleep ) Vivid dreams (from enhanced melatonin ) Increased appetite in some (rare) What Epithalon does NOT typically cause: No nausea (unlike GLP-1 agonists ) No GI upset No hormonal disruption No mood changes (may improve mood) No dependency or withdrawal Side effect comparison: Managing minor side effects: Headache: Hydrate well, usually resolves day 2-3 Drowsiness: Inject at bedtime instead of morning Vivid dreams: Enjoy them or reduce dose slightly Injection reactions : Rotate sites, ice after injection See our peptide safety and risks guide and common peptide mistakes to avoid
US$ 23.49
US$ 29.31
US$ 23.39
US$ 26.90
US$ 29.53
US$ 29.12
